# Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular Carcinoma

> **NCT06682377** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 159 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **PROCEDURE:** Radiofrequency ablation alone

## Key facts

- **NCT ID:** NCT06682377
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-05
- **Primary completion:** 2024-03-29
- **Final completion:** 2025-12-30
- **Target enrollment:** 159 (ESTIMATED)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06682377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06682377, "Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06682377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*